Kiluk Marek S, Rółkowski Roland, Zawadzki Roman J, Wojtukiewicz Marek Z
Zakład Onkologii AM w Białymstoku.
Pol Merkur Lekarski. 2002 Oct;13(76):298-301.
To differentiate malignancy-related from non-malignant exudate is important for cancer diagnosis, determining clinical stage of the disease, establishing treatment strategy, and also for prognosis. Carcinoembryonic antigen (CEA), CA 15-3 and CA 125 levels were analysed in plasma and in peritoneal fluid of 37 cancer patients (13 with breast cancer, 18 with ovarian cancer and 6 with colorectal cancer) and 15 patients with peritoneal fluid not related to malignancy. CEA, CA 15-3 and CA 125 were measured by electrochemiluminescence assay (ECL). The results were correlated with cytological and histological findings as well as clinical data. Initial observations indicate that the analysis of tumour markers CEA, CA 15-3 and CA 125 may be useful in the differential diagnosis of peritoneal effusion.
区分恶性相关渗出液与非恶性渗出液对于癌症诊断、确定疾病临床分期、制定治疗策略以及预后判断都很重要。分析了37例癌症患者(13例乳腺癌、18例卵巢癌和6例结直肠癌)血浆和腹腔积液中的癌胚抗原(CEA)、CA 15 - 3和CA 125水平,以及15例与恶性肿瘤无关的腹腔积液患者的上述指标。采用电化学发光分析法(ECL)检测CEA、CA 15 - 3和CA 125。将结果与细胞学和组织学检查结果以及临床数据进行关联分析。初步观察表明,肿瘤标志物CEA、CA 15 - 3和CA 125的分析可能有助于腹腔积液的鉴别诊断。